{"id":20,"date":"2024-06-06T18:04:24","date_gmt":"2024-06-06T18:04:24","guid":{"rendered":"https:\/\/stgilluminate.wpenginepowered.com\/?page_id=20"},"modified":"2025-10-28T12:24:36","modified_gmt":"2025-10-28T12:24:36","slug":"about-illuminate","status":"publish","type":"page","link":"https:\/\/illuminatepahstudy.com\/lv-lv\/about-illuminate\/","title":{"rendered":"About Illuminate"},"content":{"rendered":"
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Kas ir ILLUMINATE kl\u012bniskais p\u0113t\u012bjums?<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Ja Jums ir diagnostic\u0113ta plau\u0161u arteri\u0101l\u0101 hipertensija (PAH), l\u016bdzu, \u0146emiet v\u0113r\u0101, ka J\u016bs neesat viens sav\u0101 \u0101rstniec\u012bbas ce\u013c\u0101. PAH ir reta, bet nopietna un progres\u0113jo\u0161a slim\u012bba. Katru gadu tiek prognoz\u0113ts, ka t\u0101 tiks diagnostic\u0113ta aptuveni 4\u202fcilv\u0113kiem uz 1\u202fmiljonu iedz\u012bvot\u0101ju.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Pa\u0161laik m\u0113s str\u0101d\u0101jam pie potenci\u0101lu PAH \u0101rst\u0113\u0161anas meto\u017eu izstr\u0101des. P\u0113t\u012bjums ILLUMINATE ir kl\u012bniskais p\u0113t\u012bjums, kura m\u0113r\u0137is ir noskaidrot, cik labi p\u0113t\u0101m\u0101 \u0101rst\u0113\u0161anas metode darbojas un cik labi to panes pieaugu\u0161ie ar plau\u0161u arteri\u0101lo hipertensiju (PAH), kuri lieto ar\u012b citas PAH z\u0101les.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Vai esmu piem\u0113rots?<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tAnketa<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

K\u0101das ir p\u0113t\u012bjuma z\u0101les?<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\n\t\t\t\t\t\t
\n\t\t\t\t\n\t\t\t\t<\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/svg>\t\t\t\t<\/span>\n\t\t\t<\/div>\n\t\t\t\n\t\t\t\t\t\t
\n\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\tP\u0113t\u0101m\u0101s z\u0101les:<\/b> P\u0113t\u012bjuma ietvaros \u0101rst\u0113\u0161anu var veikt divos veidos. Pirmajos se\u0161os m\u0113ne\u0161os J\u016bs sa\u0146emsiet p\u0113t\u0101m\u0101s z\u0101les reizi m\u0113nes\u012b k\u0101 injekciju v\u0113n\u0101 (intravenoza inf\u016bzija). P\u0113c tam J\u016bs varat uzs\u0101kt pagarin\u0101tu \u0101rst\u0113\u0161an\u0101s periodu. \u0160aj\u0101 period\u0101 p\u0113t\u0101mo z\u0101\u013cu formu ievada zem \u0101das reizi ned\u0113\u013c\u0101 (subkut\u0101na vai SC injekcija). J\u016bs tiksiet apm\u0101c\u012bts pats ievad\u012bt p\u0113t\u012bjuma z\u0101les.\u00a0\t\t\t\t\t<\/p>\n\t\t\t\t\n\t\t\t<\/div>\n\t\t\t\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\n\t\t\t\t\t\t
\n\t\t\t\t\n\t\t\t\t<\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/svg>\t\t\t\t<\/span>\n\t\t\t<\/div>\n\t\t\t\n\t\t\t\t\t\t
\n\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\tPlacebo:<\/b> Placebo ir viela, kas izskat\u0101s k\u0101 p\u0113t\u0101m\u0101s z\u0101les, bet nesatur \u012bstas z\u0101les. P\u0113tnieki var noteikt, vai p\u0113t\u0101m\u0101 \u0101rst\u0113\u0161anas metode ir efekt\u012bva, kad izprot, vai t\u0101 darbojas lab\u0101k nek\u0101 placebo.\u00a0\t\t\t\t\t<\/p>\n\t\t\t\t\n\t\t\t<\/div>\n\t\t\t\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

<\/span> Terapijas periods<\/strong> ilgst se\u0161us m\u0113ne\u0161us. \u0160aj\u0101 period\u0101 J\u016bs p\u0113c nejau\u0161\u012bbas principa tiksiet iedal\u012bts k\u0101d\u0101 no trim \u0101rst\u0113\u0161anas grup\u0101m. Viena grupa sa\u0146ems p\u0113t\u0101mo z\u0101\u013cu formu ar mazu devu, otra grupa to sa\u0146ems ar lielu devu, bet tre\u0161ajai grupai tiks ievad\u012bts placebo. Visas p\u0113t\u012bjuma z\u0101les tiks ievad\u012btas intravenozas inf\u016bzijas veid\u0101 reizi m\u0113nes\u012b.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Kad b\u016bsiet pabeidzis Terapijas periodu un kop\u0101 ar p\u0113t\u012bjuma \u0101rstu atz\u012bsiet, ka Jums j\u0101turpina sa\u0146emt p\u0113t\u0101mo z\u0101\u013cu terapiju, J\u016bs turpin\u0101siet Pagarin\u0101to terapijas periodu<\/strong>. \u0160aj\u0101 period\u0101, ja Terapijas period\u0101 J\u016bs sa\u0146\u0113m\u0101t p\u0113t\u0101mo z\u0101\u013cu formu ar mazu devu, J\u016bs sa\u0146emsiet p\u0113t\u0101mo z\u0101\u013cu formu ar mazu devu zem \u0101das. Ja Terapijas period\u0101 J\u016bs sa\u0146\u0113m\u0101t p\u0113t\u0101mo z\u0101\u013cu formu liel\u0101 dev\u0101, J\u016bs sa\u0146emsiet p\u0113t\u0101mo z\u0101\u013cu formu liel\u0101 dev\u0101 zem \u0101das.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Ja Terapijas period\u0101 sa\u0146\u0113m\u0101t placebo, J\u016bs p\u0113c nejau\u0161\u012bbas principa tiksiet iedal\u012bts vien\u0101 no div\u0101m terapijas grup\u0101m: p\u0113t\u0101m\u0101s z\u0101les ar mazu devu vai p\u0113t\u0101m\u0101s z\u0101les ar lielu devu zem \u0101das.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u0160aj\u0101 period\u0101 visi dal\u012bbnieki p\u0113t\u0101m\u0101s z\u0101les sa\u0146ems reizi ned\u0113\u013c\u0101.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Papildus p\u0113t\u012bjuma z\u0101l\u0113m J\u016bs turpin\u0101siet lietot ar\u012b PAH z\u0101les.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Ko es varu sagaid\u012bt, ja piedal\u012b\u0161os?<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Dal\u012bba p\u0113t\u012bjum\u0101 ir piln\u012bgi br\u012bvpr\u0101t\u012bga (p\u0113c J\u016bsu izv\u0113les). J\u016bs sa\u0146emsiet inform\u0101ciju par to, kas sagaid\u0101ms, k\u0101 ar\u012b par savu lomu un pien\u0101kumiem, ja pievienosieties ILLUMINATE p\u0113t\u012bjumam. J\u016bs varat jebkur\u0101 laik\u0101 pamest p\u0113t\u012bjumu, neietekm\u0113jot savu regul\u0101ro vesel\u012bbas apr\u016bpi.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Ja pievienosieties p\u0113t\u012bjumam, no Jums tiks sagaid\u012bts, ka dar\u012bsiet noteiktas lietas. Tas ietver dal\u012bbu p\u0113t\u012bjuma apmekl\u0113jumos un noteiktu nov\u0113rt\u0113jumu un proced\u016bru, piem\u0113ram, asins un ur\u012bna anal\u012b\u017eu, veik\u0161anu, k\u0101 ar\u012b atbil\u017eu snieg\u0161anu uz jaut\u0101jumiem par J\u016bsu vesel\u012bbu. J\u016bsu dal\u012bba var ilgt no vismaz devi\u0146iem m\u0113ne\u0161iem l\u012bdz aptuveni divarpus gadiem.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Jums neb\u016bs j\u0101maks\u0101 par p\u0113t\u012bjuma proced\u016br\u0101m, apmekl\u0113jumiem, anal\u012bz\u0113m vai materi\u0101liem, kas nepiecie\u0161ami p\u0113t\u012bjumam. Jums tiks atl\u012bdzin\u0101ti pamatoti ce\u013ca izdevumi (piem\u0113ram, degviela un autobusa\/vilciena bi\u013cetes) un \u0113din\u0101\u0161anas izdevumi. Izp\u0113tes grupa to visu ar Jums apspried\u012bs.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

K\u0101 es varu piedal\u012bties?<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Ja v\u0113laties piedal\u012bties ILLUMINATE, varat aizpild\u012bt \u012bsu iepriek\u0161\u0113jas atlases anketu, lai noskaidrotu, vai atbilstat pras\u012bb\u0101m.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Vai esmu piem\u0113rots? <\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tAnketa<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Kas v\u0113l man j\u0101zina?<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

T\u0101pat k\u0101 ar vis\u0101m z\u0101l\u0113m, ar\u012b p\u0113t\u0101mo z\u0101\u013cu lieto\u0161ana var b\u016bt saist\u012bta ar riskiem. Ja J\u016bs kvalific\u0113sieties un izv\u0113l\u0113sieties piedal\u012bties, Jums tiks izsniegta inform\u0113tas piekri\u0161anas veidlapa, kur\u0101 b\u016bs paskaidroti visi iesp\u0113jamie riski un blakuspar\u0101d\u012bbas. Iesp\u0113jams ar\u012b, ka p\u0113t\u012bjuma z\u0101les var ietekm\u0113t J\u016bs nezin\u0101m\u0101 veid\u0101. J\u016bsu vesel\u012bba un dro\u0161\u012bba ir m\u016bsu galven\u0101s priorit\u0101tes, un t\u0101s tiks r\u016bp\u012bgi uzraudz\u012btas visas J\u016bsu dal\u012bbas laik\u0101.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Jums var\u0113tu b\u016bt ieteicamas papildus regul\u0101rajai apr\u016bpei veiktas p\u0101rbaudes un iesp\u0113ja sazin\u0101ties ar PAH speci\u0101listiem. Nav garantijas, ka, piedaloties \u0161aj\u0101 kl\u012bniskaj\u0101 p\u0113t\u012bjum\u0101, J\u016bs sa\u0146emsiet medic\u012bnisku ieguvumu. J\u016bsu vesel\u012bbas st\u0101voklis var uzlaboties, palikt t\u0101ds pats vai pat v\u0113l pasliktin\u0101ties. J\u016bs varat br\u012bvi atteikties no dal\u012bbas p\u0113t\u012bjum\u0101 jebkura iemesla d\u0113\u013c un jebkur\u0101 laik\u0101.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u0160aj\u0101 kl\u012bniskaj\u0101 p\u0113t\u012bjum\u0101 tiks izmantotas p\u0113t\u0101m\u0101s z\u0101les, kuru dro\u0161umu un efektivit\u0101ti regulat\u012bv\u0101s iest\u0101des v\u0113l nav piln\u012bb\u0101 nov\u0113rt\u0113ju\u0161as.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Atrodiet p\u0113t\u012bjuma vietu sav\u0101 tuvum\u0101<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Lai uzzin\u0101tu vair\u0101k par ILLUMINATE un to, vai tas var\u0113tu b\u016bt piem\u0113rots tie\u0161i Jums, l\u016bdzu, sazinieties ar tuv\u0101ko p\u0113t\u012bjuma vietu \u2014 vi\u0146i ar prieku Jums pal\u012bdz\u0113s.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Atrodiet sev tuv\u0101ko p\u0113t\u012bjuma vietu<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tVietu mekl\u0113t\u0101js<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

What is the ILLUMINATE clinical research study? If you were diagnosed with PAH, please know that you are not alone in your medical journey. PAH is a rare but serious and progressive disease. Each year, around 4 people per 1 million are expected to be diagnosed with it. Currently, we are working on developing potential […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-20","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/illuminatepahstudy.com\/lv-lv\/wp-json\/wp\/v2\/pages\/20","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/illuminatepahstudy.com\/lv-lv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/illuminatepahstudy.com\/lv-lv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/illuminatepahstudy.com\/lv-lv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/illuminatepahstudy.com\/lv-lv\/wp-json\/wp\/v2\/comments?post=20"}],"version-history":[{"count":0,"href":"https:\/\/illuminatepahstudy.com\/lv-lv\/wp-json\/wp\/v2\/pages\/20\/revisions"}],"wp:attachment":[{"href":"https:\/\/illuminatepahstudy.com\/lv-lv\/wp-json\/wp\/v2\/media?parent=20"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}